NRA NPV Forecast Calculator

Non-risk adjusted NPV forecast model with Basic and Advanced inputs – one indication, one geography
Net Present Value (NPV) calculation is a common tool to assess the value of an investigational product. Importantly, NPV forecast can help answer the key question: Should you even consider developing this product? By comparing NPVs of different products, we can judge which one is better and worth pursuing, financially speaking.

Building an NPV forecast model from scratch is even more time intensive than building a customized drug revenue forecast. Instead, you can test various Revenue, Cost, and Cash Flow assumptions using our flexible NPV forecast tool below.
General Description

Test NPV sensitivity to variations in different parameters using Tornado Plot.
Net Present Value:
BioHeights
BioHeights
BioHeights
BioHeights.com
Download: Charts Image · Inputs CSV · Data CSV

submit
Revenue Inputs
The underlying revenue algorithm is the same as the one in the Revenue Forecast Calculator. If you are not sure how to select revenue parameters, we recommend testing the revenue calculator first.
Costs
We describe Cost parameters in detail in our Profit Forecast Calculator. There, users can get insights into how cost parameters influence Gross Profit Margin, Profit Margin, and Net Income. Here, we summarize the cost parameters.
Cash Flow Parameters
Uncertainty In Inputs and NPV
Many, if not all, inputs are uncertain. Ideally, you would want to generate not a single NPV but a range of NPVs reflecting variability in inputs. Head out to our 5th calculator, NPV Sensitivity Analysis, to find out which input makes the biggest difference.


Confused or stuck? Please send any questions, comments, and requests to bioheights@pm.me.We will respond quickly.

Please Subscribe below to receive email notifications about new tools and blog posts. Also, check out our blog articles on the Insights page.

Disclaimer: This NRA NPV model/ calculator is the property of BioHeights LLC. We designed this model only for educational purposes. Importantly, this is not a financial advice. BioHeights LLC and its members are not responsible for anybody’s actions, losses, or damages resulting from using this model.

Sign Up to Receive the Latest Insights
Enter your email address to receive notifications about new articles, tools, and updates.
Sign Up Here

Solve a Problem: Oncology Product NPV

Consider a drug for B-cell Acute Lymphoblastic Leukemia (ALL). This product can treat ~20% of patients, with a one-time, single-dose infusion. Consider U.S. market only, with launch in 2026, exclusivity loss in 2033, and no competition. Price per dose $475k. Cost per dose $50k. R&D expenses $500M. Launch Expenses $100M. Royalties 5%.

1. How would the value of the product change if the product can receive accelerated approval and be launched 2 years earlier, in 2024? (keep exclusivity year as 2033)
  X   Decrease 35 times
  V   Increase 35 times
  X   No change
  X   Decrease 8 times
  X   Increase 8 times

2. How would the value of the product change if it is licensed by a Large Pharma versus a Small Company? Assume WACC for Large Pharma 5%, for Small Co 20%. (Launch in 2026)
  X   $500M : $120M
  X   $200M : -$100M
  X   $100M : $500M
  V   $200M : -$120M